Zanubrutinib Demonstrates Superior Progression-Free Survival (PFS) Compared with Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL): Results from Final Analysis of ALPINE Randomized Phase 3 Study

Brown, JR (author)

Eichhorst, B (author)

Hillmen, P (author)

show more...

Lamanna, N (author)

O'Brien, SM (author)

Tam, CS (author)

Qiu, LG (author)

Kazmierczak, M (author)

Jurczak, W (author)

Zhou, KS (author)

Simkovic, M (author)

Mayer, J (author)

Gillespie-Twardy, AL (author)

Ferrajoli, A (author)

Ganly, PS (author)

Weinkove, R (author)

Grosicki, S (author)

Mital, A (author)

Robak, T (author)

Osterborg, A (author)

Yimer, HA (author)

Salmi, T (author)

Wang, M (author)

Fu, LN (author)

Li, J (author)

Wu, K (author)

Cohen, A (author)

Shadman, M (author)

show less...

American Society of Hematology, 2022

2022

English.

In: BLOOD. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 140, s. 19-23

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Conference paper (other academic/artistic)